ArticleBritish journal of cancer2016

Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant.

Z Zakaria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.